India marks its fifth $1B drugmaker

Zydus Cadila has joined the $1 billion-turnover club of Indian drugmakers. It was a $400 million company just four years ago, and planned for the ascent to $1 billion. It hopes to reach $3 billion by 2015. Cadila is welcomed to the club by Cipla, Ranbaxy, GSK and Piramal Group. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.